InDex Pharmaceuticals AB of Sweden said that data from a compassionate use programme of its experimental therapy for treating ulcerative colitis has been published in the journal, Inflammatory Bowel Diseases. ---Subscribe to MedNous to access this article--- Clinical Research Company News
